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Asymptomatic 50-75% Internal Carotid Artery Steno-
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sion and Ipsilateral Neurological Symptoms
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Objectives: This study identified characteristics of pa-
tients with moderate internal carotid artery stenosis that are
at increased risk for disease progression.
Methods: Patients with asymptomatic moderate inter-
nal carotid disease (peak systolic velocity [PSV] 125cm/
sec and end diastolic velocity [EDV] 125cm/sec by
duplex ultrasonography) correlating to 50-75% diameter
reduction were followed for 3 years. Progression to greater
than 75% diameter reduction (EDV  125cm/sec) or
presentation with focal neurological symptoms (stroke,
amaurosis fugax, transient ischemic attack [TIA]) was doc-
umented. Co-morbidities, smoking status and medications
were recorded. Log-rank testing, Wilcoxson models, and
Kaplan-Meier plots provided statistical analysis.
Results: During 3 year follow up, 26 (9%) of 288
patients (137 men, 151 women) developed symptoms
[stroke: 9 (3.1%), TIA: 3 (1%), amaurosis fugax: 3 (1%)] or
asymptomatic increase in diameter to 75% [11 (3.8%)].
All-cause mortality was 11% (33 patients). 17 patients
(5.9%) underwent carotid endarterectomy and 5 (1.7%)
had carotid stent placement. The event incidence was sig-
nificantly higher for men (P.02), but survival was not
different. The rate of disease progression and/or develop-
ment of symptoms was 5.5% at 12 months and increased to
7.2% by 24 months. Co-morbidities with the highest asso-
ciated event incidences were coronary artery disease [CAD]
(8.1%), hyperlipidemia (7.3%), and hypertension [HTN]
(6.7%). Medications associated with lower event incidences
were insulin (2.8%) and angiotensin receptor blockers
(1.9%).
Conclusions: 9% of patients with asymptomatic mod-
erate carotid stenosis progressed to severe stenosis or de-
veloped ipsilateral neurological symptoms at three year
follow-up. The rate of asymptomatic disease progression or
symptom development was to 7.2% by 24 months. Male
patients with CAD, hyperlipidemia, and HTN are at in-
creased risk and are candidates for frequent screening
and/or early intervention.
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Objectives: Cerebral hyperperfusion syndrome
(CHS) after carotid endarterectomy (CEA) is a potential
life-threatening complication. Therefore, early identifi-
cation and treatment of patients at risk is essential. CHS
can be predicted by a doubling of post-operative trans-
cranial Doppler (TCD) derived middle cerebral artery
blood velocity (V) as compared to pre-operative values.
However, in 15% of CEA patients an adequate TCD-
signal cannot be obtained due to an insufficient temporal
bone window. Near infrared spectroscopy (NIRS), esti-
mating the frontal lobe oxygenation (rSO2) could be
used as an alternative cerebral monitoring technique. We
assessed the value of NIRS and peri-operative TCD to
predict CHS after CEA.
Methods: In total, 151 consecutive patients under-
going CEA under general anesthesia having a sufficient
TCD window were prospectively included. V and rSO2
measured before induction of anesthesia were compared
to measurements in the first postoperative hour (
V,

rSO2 respectively). Logistic regression analysis was
performed to determine the relationship between 
V
and 
rSO2 and the occurrence of CHS. ROC curve
analysis was used to determine the optimal cut-off values.
Results: Seven patients developed CHS. 
V and

rSO2 differed between CHS and non-CHS patients
(meanSD), i.e. 6329% vs 2445% and 96% vs 19%
respectively (P .05). Increases in 
V and 
rSO2 were
significantly associated with the occurrence of CHS, inde-
pendent of age and gender, OR 1.47 (95% CI 1.04-2.09)
per 30% increase in V and OR 1.77 (1.06-2.96) per 5%
increase in rSO2. ROC curve analysis showed an AUC of
0.843 for 
V and an optimal cut-off value of 62% increase
(PPV 0.31, NPV 0.98). And an AUC of 0.793 for 
rSO2
and an optimal cut-off value of 3% rSO2 increase (PPV
0.10, NPV 0.99).
Conclusions: Both TCD and NIRS seem to be useful
to safely exclude patients from being at risk to develop
CHS. However, due to the limited number of CHS cases
our results need to be validated in a larger study.
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